Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination-Reference-Cited by-同舟云学术

Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination

Published:2023-09 Issue: Volume:95 Page:104743
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Ziegler Laura^ORCID,Klemis Verena^ORCID,Schmidt Tina^ORCID,Schneitler Sophie^ORCID,Baum Christina,Neumann Jürgen,Becker Sören L.^ORCID,Gärtner Barbara C.^ORCID,Sester Urban^ORCID,Sester Martina^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference34 articles.

1. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine;Polack;N Engl J Med,2020

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

4. The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines;Cavaleri;Lancet,2021

5. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans;Sahin;Nature,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morning administration enhances humoral response to SARS-CoV-2 vaccination in kidney transplant recipients;American Journal of Transplantation;2024-09

2. Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain;Journal of Virology;2024-08-28

3. Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity;Molecular Therapy;2024-05

4. Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses;eBioMedicine;2024-05

5. Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain;2024-04-07